|
Volumn 15, Issue SUPPL. 4, 2000, Pages
|
From pharmacological profiles to clinical outcomes
|
Author keywords
Amisulpride; Clozapine; Dopamine receptors; Frontal cortex; Haloperidol; Limbic system; Negative symptoms; Positive symptoms; Postsynaptic; Presynaptic; Risperidone; Schizophrenia
|
Indexed keywords
AMISULPRIDE;
DOPAMINE 2 RECEPTOR;
DOPAMINE 2 RECEPTOR BLOCKING AGENT;
DOPAMINE 3 RECEPTOR;
DOPAMINE 3 RECEPTOR BLOCKING AGENT;
DOPAMINE 4 RECEPTOR;
COGNITIVE DEFECT;
CONFERENCE PAPER;
DOPAMINERGIC NERVE CELL;
DRUG EFFICACY;
DRUG INDICATION;
DRUG RECEPTOR BINDING;
DRUG RESEARCH;
DRUG SELECTIVITY;
DRUG TOLERABILITY;
FRONTAL CORTEX;
HUMAN;
HYPOTHESIS;
LIMBIC CORTEX;
NEGATIVE SYNDROME;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
PSYCHOPHARMACOLOGY;
SCHIZOPHRENIA;
ANTIPSYCHOTIC AGENTS;
FRONTAL LOBE;
HUMANS;
LIMBIC SYSTEM;
RECEPTORS, DOPAMINE;
SCHIZOPHRENIA;
SULPIRIDE;
|
EID: 0034470192
PISSN: 02681315
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (21)
|
References (18)
|